Cargando…
miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1
Multidrug resistance-associated protein 1 (MRP1) is an important efflux transporter and overexpression of MRP1 usually leads to chemoresistance in breast cancer. Here, we found MRP1 overexpressed in human breast cancer tissues and breast cancer cell lines (compared with normal breast tissues and cel...
Autores principales: | Gao, Man, Miao, Lingling, Liu, Mingxia, Li, Chenggang, Yu, Cunzhi, Yan, Hong, Yin, Yongxiang, Wang, Yizheng, Qi, Xinming, Ren, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312343/ https://www.ncbi.nlm.nih.gov/pubmed/27487127 http://dx.doi.org/10.18632/oncotarget.10845 |
Ejemplares similares
-
MiR-1254 suppresses HO-1 expression through seed region-dependent silencing and non-seed interaction with TFAP2A transcript to attenuate NSCLC growth
por: Pu, Mengfan, et al.
Publicado: (2017) -
Suppression of circ_0008932 inhibits tumor growth and metastasis in osteosarcoma by targeting miR-145-5p
por: Cao, Chenggang, et al.
Publicado: (2021) -
MiR‐145 in cancer therapy resistance and sensitivity: A comprehensive review
por: Xu, Wenxiu, et al.
Publicado: (2020) -
Expression levels of atherosclerosis-associated miR-143 and miR-145 in the plasma of patients with hyperhomocysteinaemia
por: Liu, Kejian, et al.
Publicado: (2017) -
The miR-143/miR-145 cluster and the tumor microenvironment: unexpected roles
por: Almeida, Maria Inês, et al.
Publicado: (2016)